Global Regulatory Strategy & Market Access
Regulatory Strategy for Global Market Access
From regulatory pathway selection to dossier submission and lifecycle management, we help pharmaceutical and healthcare companies navigate complex global requirements with clarity and confidence.
Regulatory clarity before regulatory commitment.
Common Technical Document
The Regulatory Challenge
Regulatory Complexity Should Not Become a Commercial Bottleneck
Most delays are not caused by science. They are caused by requirements identified too late — after the data package is fixed, the batches are made and the launch date is set.
- 01Product development
- 02Regulatory pathway
- 03Gap assessment
- 04Dossier strategy
- 05Technical documentation
- 06Submission
- 07Health authority interaction
- 08Approval
- 09Lifecycle management
Our Approach
One Regulatory Strategy. Multiple Global Markets.
We integrate regulatory strategy, scientific assessment, documentation and submission execution into a single accountable workstream, so decisions in one market do not create rework in the next.
Strategy
Regulatory pathway selection, country prioritisation and market-entry planning before development spend is committed.
Intelligence
Regulatory landscape, precedent and requirement analysis mapped to your product and target markets.
Execution
Dossier authoring, compilation, publishing and submission support built for first-cycle readiness.
Lifecycle
Variations, renewals, commitments, labeling updates and post-approval change management.
Core Services
Regulatory Capability Across the Product Lifecycle
Engage us for a single deliverable or for end-to-end regulatory ownership of a product across markets.
Medical Device & IVD
Medical Device & IVD Regulatory Strategy
EU MDR, EU IVDR, UKCA/UK MDR and FDA routes assessed together, so the technical documentation you build supports more than one market.
- 01Classification
- 02Regulatory pathway
- 03Technical documentation
- 04Clinical / performance evidence
- 05Conformity assessment
- 06Registration
- 07Post-market surveillance
Global Coverage
Global Requirements. Local Regulatory Intelligence.
Registration requirements diverge in the detail: dossier format, legalisation, local testing, labeling and post-approval obligations. We plan for those differences up front.
North America
FDA · Health Canada
NDA, ANDA, 505(b)(2), BLA, 510(k), De Novo, PMA and Canadian NDS/ANDS routes.
Europe
EMA · EU Member States · MHRA · Swissmedic
Centralised, decentralised, mutual recognition and national procedures; EU MDR/IVDR.
Asia-Pacific
TGA · Medsafe · PMDA · NMPA · MFDS · ASEAN
ACTD/CTD hybrids, local testing expectations and in-country representation.
Middle East
Saudi FDA · UAE · Jordan · Qatar · Oman · Kuwait
GCC centralised and national registration routes, GMP and pricing requirements.
Africa
South Africa · Egypt · Kenya · Nigeria · Ghana · Tanzania · Uganda
SAHPRA, EAC joint assessment, WHO CRP and national dossier formats.
Latin America
Brazil · Mexico · Argentina · Chile · Colombia · Peru
ANVISA, COFEPRIS and regional dossier, legalisation and labeling requirements.
Built Around You
I represent a…
Who We Help
Start From Where Your Product Is Today
Regulatory Tools
Identify the Pathway Before Investing in the Submission
Structured, self-service tools that give you a defensible starting position — reviewed by regulatory professionals when you want to go further.
Regulatory Pathway Finder
Answer eight questions and receive an indicative pathway, documentation set and known risks.
Dossier Readiness Assessment
Score your CTD package against target-market expectations across Modules 1–5.
CTD Explorer
Module-by-module purpose, typical documents and common deficiencies.
Ready to Turn Regulatory Complexity Into a Market-Entry Strategy?
Tell us where your product is today, where you want to go, and the regulatory challenge standing in the way.